CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Open-market sale President and Head of R&D sold 4,092 shares at $6.90 ($28,250)
- 4 Open-market sale Chief Financial Officer sold 1,050 shares at $6.90 ($7,249)
- 4 Open-market sale Chief Medical Officer sold 2,617 shares at $6.90 ($18,067)
- 4 Open-market sale Chief Executive Officer sold 5,255 shares at $6.90 ($36,279)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Exit or restructuring costs
Page 15 of 32 · 631 filings